Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1

ABSTRACT HLA class I-associated polymorphisms identified at the population level mark viral sites under immune pressure by individual HLA alleles. As such, analysis of their distribution, frequency, location, statistical strength, sequence conservation, and other properties offers a unique perspective from which to identify correlates of protective cellular immunity. We analyzed HLA-associated HIV-1 subtype B polymorphisms in 1,888 treatment-naïve, chronically infected individuals using phylogenetically informed methods and identified characteristics of HLA-associated immune pressures that differentiate protective and nonprotective alleles. Over 2,100 HLA-associated HIV-1 polymorphisms were identified, approximately one-third of which occurred inside or within 3 residues of an optimally defined cytotoxic T-lymphocyte (CTL) epitope. Differential CTL escape patterns between closely related HLA alleles were common and increased with greater evolutionary distance between allele group members. Among 9-mer epitopes, mutations at HLA-specific anchor residues represented the most frequently detected escape type: these occurred nearly 2-fold more frequently than expected by chance and were computationally predicted to reduce peptide-HLA binding nearly 10-fold on average. Characteristics associated with protective HLA alleles (defined using hazard ratios for progression to AIDS from natural history cohorts) included the potential to mount broad immune selection pressures across all HIV-1 proteins except Nef, the tendency to drive multisite and/or anchor residue escape mutations within known CTL epitopes, and the ability to strongly select mutations in conserved regions within HIV's structural and functional proteins. Thus, the factors defining protective cellular immune responses may be more complex than simply targeting conserved viral regions. The results provide new information to guide vaccine design and immunogenicity studies.

[1]  Z. Brumme,et al.  HLA class I sequence-based typing using DNA recovered from frozen plasma. , 2012, Journal of immunological methods.

[2]  B. Walker,et al.  HIV control through a single nucleotide on the HLA-I locus , 2012, Retrovirology.

[3]  Todd M. Allen,et al.  TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection , 2012, Nature Immunology.

[4]  J. Carlson,et al.  Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein Vpu. , 2012, Biochemical and biophysical research communications.

[5]  Sebastian Bonhoeffer,et al.  Estimating the Fitness Cost of Escape from HLA Presentation in HIV-1 Protease and Reverse Transcriptase , 2012, PLoS Comput. Biol..

[6]  D. Heckerman,et al.  Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity , 2012, Journal of Virology.

[7]  Tommy F. Liu,et al.  Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool , 2012, Journal of Clinical Microbiology.

[8]  Huldrych F. Günthard,et al.  Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection , 2012, PLoS pathogens.

[9]  D. Heckerman,et al.  Widespread Impact of HLA Restriction on Immune Control and Escape Pathways of HIV-1 , 2012, Journal of Virology.

[10]  Thurston H. Y. Dang,et al.  HLA B*5701-Positive Long-Term Nonprogressors/Elite Controllers Are Not Distinguished from Progressors by the Clonal Composition of HIV-Specific CD8+ T Cells , 2012, Journal of Virology.

[11]  B. Walker,et al.  HLA-B*57 Micropolymorphism Shapes HLA Allele-Specific Epitope Immunogenicity, Selection Pressure, and HIV Immune Control , 2011, Journal of Virology.

[12]  Huldrych F Günthard,et al.  2011 update of the drug resistance mutations in HIV-1. , 2011, Topics in antiviral medicine.

[13]  J. Fellay,et al.  Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints , 2011, Retrovirology.

[14]  N. Letvin,et al.  Mutations in a Dominant Nef Epitope of Simian Immunodeficiency Virus Diminish TCR:Epitope Peptide Affinity but not Epitope Peptide:MHC Class I Binding , 2011, The Journal of Immunology.

[15]  D. Heckerman,et al.  Translation of HLA–HIV Associations to the Cellular Level: HIV Adapts To Inflate CD8 T Cell Responses against Nef and HLA-Adapted Variant Epitopes , 2011, The Journal of Immunology.

[16]  Feng Gao,et al.  Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections , 2011, PLoS pathogens.

[17]  Brigitte Autran,et al.  Escape from highly effective public CD8+ T-cell clonotypes by HIV. , 2011, Blood.

[18]  Praphan Phanuphak,et al.  A Novel Immunodominant CD8+ T Cell Response Restricted by a Common HLA-C Allele Targets a Conserved Region of Gag HIV-1 Clade CRF01_AE Infected Thais , 2011, PloS one.

[19]  Z. Brumme,et al.  Immune-mediated attenuation of HIV-1. , 2011, Future virology.

[20]  Todd M. Allen,et al.  Coordinate linkage of HIV evolution reveals regions of immunological vulnerability , 2011, Proceedings of the National Academy of Sciences.

[21]  D. Heckerman,et al.  HLA-A*7401–Mediated Control of HIV Viremia Is Independent of Its Linkage Disequilibrium with HLA-B*5703 , 2011, The Journal of Immunology.

[22]  David Heckerman,et al.  Progression to AIDS in South Africa Is Associated with both Reverting and Compensatory Viral Mutations , 2011, PloS one.

[23]  Todd M. Allen,et al.  Increased Breadth and Depth of Cytotoxic T Lymphocytes Responses against HIV-1-B Nef by Inclusion of Epitope Variant Sequences , 2011, PloS one.

[24]  T. Schumacher,et al.  An Early HIV Mutation within an HLA-B*57-Restricted T Cell Epitope Abrogates Binding to the Killer Inhibitory Receptor 3DL1 , 2011, Journal of Virology.

[25]  Peter B. Gilbert,et al.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial , 2011, Nature Medicine.

[26]  Daniel C Douek,et al.  Bias in the αβ T‐cell repertoire: implications for disease pathogenesis and vaccination , 2011, Immunology and cell biology.

[27]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[28]  Philip J. R. Goulder,et al.  Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics , 2010, PloS one.

[29]  D. Heckerman,et al.  Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses. , 2010, Vaccine.

[30]  S. Buus,et al.  Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.

[31]  Todd M. Allen,et al.  Effects of thymic selection of the T cell repertoire on HLA-class I associated control of HIV infection , 2010, Nature.

[32]  D. Heckerman,et al.  Adaptive Interactions between HLA and HIV-1: Highly Divergent Selection Imposed by HLA Class I Molecules with Common Supertype Motifs , 2010, The Journal of Immunology.

[33]  James McCluskey,et al.  Constraints within major histocompatibility complex class I restricted peptides: Presentation and consequences for T-cell recognition , 2010, Proceedings of the National Academy of Sciences.

[34]  James Theiler,et al.  Mosaic Vaccines Elicit CD8+ T lymphocyte Responses in Monkeys that Confer Enhanced Immune Coverage of Diverse HIV Strains , 2010, Nature Medicine.

[35]  D. Heckerman,et al.  Viral adaptation to immune selection pressure by HLA class I–restricted CTL responses targeting epitopes in HIV frameshift sequences , 2010, The Journal of experimental medicine.

[36]  D. Heckerman,et al.  CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription , 2010, The Journal of experimental medicine.

[37]  Bette Korber,et al.  Mosaic HIV-1 Vaccines Expand the Breadth and Depth of Cellular Immune Responses in Rhesus Monkeys , 2010, Nature Medicine.

[38]  Elizabeth T. Cirulli,et al.  Common Genetic Variation and the Control of HIV-1 in Humans , 2009, PLoS genetics.

[39]  M. John,et al.  Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen–restricted immune pressure , 2009, Hepatology.

[40]  David W. Haas,et al.  HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins , 2009, PloS one.

[41]  D. Heckerman,et al.  Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study , 2009, Retrovirology.

[42]  Alan S. Perelson,et al.  The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.

[43]  David Heckerman,et al.  Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.

[44]  Hendrik Streeck,et al.  The role of IFN-γ Elispot assay in HIV vaccine research , 2009, Nature Protocols.

[45]  David Heckerman,et al.  HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering , 2009, Journal of Virology.

[46]  Todd M. Allen,et al.  Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T Lymphocytes , 2009, Journal of Virology.

[47]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[48]  Nicole Frahm,et al.  How to Optimally Define Optimal Cytotoxic T Lymphocyte Epitopes in HIV Infection , 2009 .

[49]  M Setterholm,et al.  The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. , 2009, Tissue antigens.

[50]  D. Richman,et al.  2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.

[51]  David Heckerman,et al.  Phylogenetic Dependency Networks: Inferring Patterns of CTL Escape and Codon Covariation in HIV-1 Gag , 2008, PLoS Comput. Biol..

[52]  David Heckerman,et al.  Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection , 2008, AIDS.

[53]  David Heckerman,et al.  Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.

[54]  D. Heckerman,et al.  Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.

[55]  Tanmoy Bhattacharya,et al.  HLA Class I-Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load , 2008, Journal of Virology.

[56]  S. Hammer,et al.  The challenge of HIV-1 subtype diversity. , 2008, The New England journal of medicine.

[57]  David Heckerman,et al.  Statistical Resolution of Ambiguous HLA Typing Data , 2008, PLoS Comput. Biol..

[58]  D. Heckerman,et al.  Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. , 2008, AIDS research and human retroviruses.

[59]  David Heckerman,et al.  Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads , 2008, PloS one.

[60]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[61]  James I Mullins,et al.  HIV-1 Group M Conserved Elements Vaccine , 2007, PLoS pathogens.

[62]  David A. Price,et al.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.

[63]  J. Borghans,et al.  HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24 , 2007, PLoS ONE.

[64]  O. Lund,et al.  NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.

[65]  D. Watkins,et al.  Pol-Specific CD8+ T Cells Recognize Simian Immunodeficiency Virus-Infected Cells Prior to Nef-Mediated Major Histocompatibility Complex Class I Downregulation , 2007, Journal of Virology.

[66]  Raymond T Chung,et al.  Human leukocyte antigen–associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution , 2007, Hepatology.

[67]  David Heckerman,et al.  Leveraging Hierarchical Population Structure in Discrete Association Studies , 2007, PloS one.

[68]  David Heckerman,et al.  Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 , 2007, PLoS pathogens.

[69]  Asier Sáez-Cirión,et al.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.

[70]  David Heckerman,et al.  Coping with Viral Diversity in HIV Vaccine Design , 2007, PLoS Comput. Biol..

[71]  D. Heckerman,et al.  Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.

[72]  D. Watkins,et al.  Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1 , 2007, The Journal of Immunology.

[73]  Mathias M Schuler,et al.  SYFPEITHI: database for searching and T-cell epitope prediction. , 2007, Methods in molecular biology.

[74]  James Theiler,et al.  Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants , 2007, Nature Medicine.

[75]  David Heckerman,et al.  CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.

[76]  B. Walker,et al.  Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype , 2006, The Journal of Immunology.

[77]  Todd M. Allen,et al.  Mutually Exclusive T-Cell Receptor Induction and Differential Susceptibility to Human Immunodeficiency Virus Type 1 Mutational Escape Associated with a Two-Amino-Acid Difference between HLA Class I Subtypes , 2006, Journal of Virology.

[78]  M. McElrath,et al.  Preservation of T Cell Proliferation Restricted by Protective HLA Alleles Is Critical for Immune Control of HIV-1 Infection1 , 2006, The Journal of Immunology.

[79]  Todd M. Allen,et al.  Hitting HIV where it hurts: an alternative approach to HIV vaccine design. , 2006, Trends in immunology.

[80]  I. James,et al.  Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus Infection , 2006, Journal of Virology.

[81]  B. Walker,et al.  Motif Inference Reveals Optimal CTL Epitopes Presented by HLA Class I Alleles Highly Prevalent in Southern Africa1 , 2006, The Journal of Immunology.

[82]  Bette T. Korber,et al.  Relative Dominance of Gag p24-Specific Cytotoxic T Lymphocytes Is Associated with Human Immunodeficiency Virus Control , 2006, Journal of Virology.

[83]  Tao Dong,et al.  Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope , 2006, Nature Immunology.

[84]  Christian Brander,et al.  Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution , 2005, Journal of Virology.

[85]  Philip J. R. Goulder,et al.  HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response1 , 2005, The Journal of Immunology.

[86]  D. Cooper,et al.  A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1. , 2005, AIDS research and human retroviruses.

[87]  Andrew K. Sewell,et al.  Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA , 2005, The Journal of experimental medicine.

[88]  A. McMichael,et al.  Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA‐B*2705 , 2005, European journal of immunology.

[89]  Bette Korber,et al.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.

[90]  Richard A Koup,et al.  T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. , 2004, Immunity.

[91]  B. Walker,et al.  Immune Escape Precedes Breakthrough Human Immunodeficiency Virus Type 1 Viremia and Broadening of the Cytotoxic T-Lymphocyte Response in an HLA-B27-Positive Long-Term-Nonprogressing Child , 2004, Journal of Virology.

[92]  Edward C Holmes,et al.  Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies. , 2004, The Journal of infectious diseases.

[93]  Philip J. R. Goulder,et al.  HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.

[94]  M. Altfeld,et al.  Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection , 2004, The Journal of experimental medicine.

[95]  Yoshiyuki Nagai,et al.  Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte (CTL) Epitopes Are Major Escape Mechanisms from CTL Immune Pressure in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[96]  Stephen J O'Brien,et al.  The influence of HLA genotype on AIDS. , 2003, Annual review of medicine.

[97]  David W. Haas,et al.  A Multi-Investigator/Institutional DNA Bank for AIDS-Related Human Genetic Studies: AACTG Protocol A5128 , 2003, HIV clinical trials.

[98]  B. Korber,et al.  Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. , 2003, Journal of acquired immune deficiency syndromes.

[99]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[100]  O. Yang.  Will we be able to 'spot' an effective HIV-1 vaccine? , 2003, Trends in immunology.

[101]  D. Strick,et al.  Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.

[102]  Andrew D. Smith,et al.  A Transition Probability Model for Amino Acid Substitutions from Blocks , 2003, J. Comput. Biol..

[103]  V. Calvez,et al.  Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection , 2002, AIDS.

[104]  Feng Gao,et al.  Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.

[105]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[106]  M. Mulligan,et al.  Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.

[107]  M. Carrington,et al.  HLA and AIDS: a cautionary tale. , 2001, Trends in molecular medicine.

[108]  S G Marsh,et al.  The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. , 2001, Human immunology.

[109]  J J Goedert,et al.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.

[110]  R. Kaul,et al.  CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. , 2001, The Journal of clinical investigation.

[111]  Edward C. Holmes,et al.  Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.

[112]  E. Rosenberg,et al.  Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and Children , 2000, Journal of Virology.

[113]  Peter Parham,et al.  The HLA FactsBook , 1999 .

[114]  Simon Mallal,et al.  The Western Australian HIV cohort study , 1998 .

[115]  S. Mallal,et al.  The Western Australian HIV Cohort Study, Perth, Australia. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[116]  P. Klenerman,et al.  Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[118]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[119]  J. Goedert,et al.  Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.

[120]  R. Koup.  Virus escape from CTL recognition , 1994, The Journal of experimental medicine.

[121]  K. Parker,et al.  Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. , 1992, Journal of immunology.

[122]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.

[123]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[124]  S D Kemp,et al.  Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). , 1989, Science.

[125]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[126]  H. Akaike.  A new look at the statistical model identification , 1974 .

[127]  K. Serra.  BELLEVUE Hospital Center. , 1956, Medical times.